EKO International Corp. (EKNL)

Market Cap	32.00 -89.9%
Revenue (ttm)	-970.19K
Net Income	30.88K
EPS	n/a
Shares Out	31.68M
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	0.000001
Previous Close	n/a
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0002
Beta	7.95
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About EKO International

EKO International Corp., through its joint venture interest in NeuroVasc Clinical Inc., promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada. The company, through its joint venture interest in NeuroVasc Clinical Inc., also sets up and/or manage clinics to treat patients using FREMSTM equipment. EKO International Corp. is based in Burlington, Canada.

• Industry: Conglomerates
• Sector: Industrials
• Employees: 8
• Stock Exchange: OTCMKTS
• Ticker Symbol: EKNL

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 10, 2026

Data Sources Report a data error